EP0973946A1 - Biological assay for testing the carcinogenic properties of a substance - Google Patents
Biological assay for testing the carcinogenic properties of a substanceInfo
- Publication number
- EP0973946A1 EP0973946A1 EP98917309A EP98917309A EP0973946A1 EP 0973946 A1 EP0973946 A1 EP 0973946A1 EP 98917309 A EP98917309 A EP 98917309A EP 98917309 A EP98917309 A EP 98917309A EP 0973946 A1 EP0973946 A1 EP 0973946A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- assay
- cells
- dna
- gene
- yeast
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
Definitions
- the present invention relates to a biological assay and assay reagents for testing the carcinogenic properties of a test substance.
- the assay is useful for screening potential anti-cancer drugs as well as for testing the carcinogenic properties of food components.
- DNA repair is an essential process in all organisms from prokaryotes to eukaryotes. Defective DNA repair in higher eukaryotes such as humans is an important factor in the aetiology of both hereditary and sporadic carcinomas.
- initiation is a single-cell event which leads to the development of a precancerous lesion by clonal expansion.
- Progression to an invasive tumour is a prolonged process requiring the acquisition of several further mutations in genes controlling cell proliferation and differentiation.
- the spontaneous mutation rate in normal cells is relatively low it suggests that an early event in the pathway of tumourgenesis is a mutation that confers a so- called "mutator" phenotype.
- HNPCC Hereditary non-polyposis cancer
- HNPCC is an autosomal dominant disease in which multiple members of a family suffer early onset colon cancer in the absence of polyp formation.
- HNPCC tumours that exhibit microsatellite instability over 50% contain mutations in the HNPCC-linked hMSH2 gene on chromosome 2 and about 20-30% contain mutations in the HNPCC-linked hMLHl gen on chromosome 3 (Umar, A. & Kunkel, T.A., 1996).
- HNPCC-Lynch syndromes I and II is a common cancer predisposition syndrome that is autosomal dominant in nature.
- Lynch I families suffer early onset colorectal cancer, while Lynch II kindreds are also susceptible to extra colonic epithelial tumours of the endometrium, ovary, stomach, small intestine, kidney and ureter.
- the link between microsatellite instability and cancer is demonstrated by the fact that a subset of sporadic colon cancers and the majority of tumours occurring in HNPCC patients contain frequent mutations in the simple microsatellite sequences (A)n, (GGC)n, or (CA)n. These mutations seem to be tumour specific with each cell containing thousands of microsatellite mutations.
- mismatch repair pathways of both lower and higher eukaryotes share extensive homology.
- homologues of the human mismatch repair pathway exist in Saccharomyces cerevisiae. Henderson and Petes, Mol. and Cell. Biol. , June 1992, 12, No. 6, p.2749- 2757 have constructed reporter gene expression vectors for studying spontaneous frameshift mutations.
- the vectors are based on a plasmid having the LEU2 promoter and the first 12 codons of the yeast LEU2 protein fused to the eighth codon of the E. coli ⁇ -galactosidase gene (lacZ). They inserted various oligonucleotides containing simple repetitive DNAs into the Bar ⁇ l site near the beginning of the ⁇ - galactosidase gene.
- the inserts did not shift the reading frame so that ⁇ -galactosidase expression occurred unless a frameshift mutation occurred in the host (yeast) cells. Such events were visible as white colonies when the cells were grown on a medium containing Xgal.
- an assay for testing the carcinogenic properties of a test substance comprising: (i) introducing into cells a reporter gene expression vector comprising a repetitive DNA sequence which exhibits instability in cancer cells, whereby instability of the repetitive DNA sequence affects expression of the reporter gene; (ii) exposing the resulting cells to the test substance; and (iii) determining whether the test substance is carcinogenic or anticarcinogenic by comparing the frequency of reporter gene expression in the resulting cells with the frequency of reporter gene expression in cells which have not been exposed to the test substance.
- cancergenic properties is intended to embrace the ability of the test substance to inhibit cancer as well as to cause cancer, that is, the term embraces both carcinogenic and anti-carcinogenic properties.
- instability we mean a change in the size of the DNA sequence, normally by additions or deletions that are not a multiple of 3 bp. Such changes in size alter the reading frame for transcription of adjacent genes and are known as frameshift mutations.
- the repetitive DNA sequence (often referred to as microsatellite DNA) comprises a poly d(AC/TG) tract and/or a poly d(GT/CA) tract, although the tract may comprise a single nucleotide eg. poly d(G) or poly d(A).
- the length of the repetitive DNA tract can be varied and is preferably selected according to the length of the repetitive sequence identified as being unstable in the cancer cell of interest.
- the length of the repetitive sequence is conveniently 8 to 60 nucleotides, more preferably 16 to 32 and especially 16.
- reporter gene expression vector is intended to cover any vector into which a reporter gene has been inserted so that, on introduction into a suitable host cell, the reporter gene will be transcribed and translated to produce the protein product of the reporter gene.
- the expression vector can be provided in a variety of forms eg. a plasmid, a 'phage or a virus.
- the reporter gene expression vector comprises a promoter region of a gene which is normally expressed in the host cell fused to a sequence encoding a reporter gene product which can be expressed in the host cell.
- a repetitive DNA sequence which exhibits instability in cancer cells is inserted downstream of the promoter region into the open-reading frame of the reporter gene sequence.
- the open-reading frame (ORF) will be understood by skilled persons to mean a DNA sequence which contains a series of triplets coding for amino acids without any termination codons.
- the insertion preferably "knocks" the promoter/reporter gene fusion out- of-frame (+ 1 or -1 reading frame) so that the reporter gene is not expressed. Hence expression of the reporter gene only occurs if the inserted repetitive sequence changes size (exhibits instability) so that the correct reading frame of the reporter gene is established.
- the insertion does not knock the promoter/reporter gene fusion out of frame so that expression of the reporter gene occurs unless the inserted repetitive sequence exhibits instability so that it knocks the promoter/reporter gene out-of-frame.
- promoter sequences and reporter gene sequences which can be used in a given host cell be it yeast, human or bacterial.
- the reporter gene expression vectors disclosed by Henderson and Petes (1992), Levinson and Gutman (1987), and Strand et al (1993) are incorporated herein by reference.
- the reporter gene expression vector is provided in the form of a low or high copy number plasmid, or an integrative plasmid, that is, a plasmid which lacks a host cell origin of replication and must therefore be integrated into the host cell genome for stable maintenance in the host cells.
- the reporter gene comprises a gene whose expression product gives rise to a visible change in the host cell.
- the gene product may produce a colour change or fluorescence.
- a particularly preferred reporter gene system comprises the lacZ gene which encodes the enzyme ⁇ -galactosidase. ⁇ -galactosidase expression can be detected as a blue colour in colonies growth on a medium containing Xgal. Colonies which do not express ⁇ -galactosidase appear as white colonies.
- use of the vector comprising the lacZ reporter gene according to a preferred embodiment provides a simple blue/white colour test for screening the carcinogenic effect of a test substance.
- the cells used in the assay are eukaryotic cells, preferably yeast cells or human cells, and especially eukaryotic cells which have a defect in repetitive DNA instability repair mechanisms, especially the mismatch repair pathway.
- yeast cells or human cells eukaryotic cells which have a defect in repetitive DNA instability repair mechanisms, especially the mismatch repair pathway.
- homologues of the human mismatch repair pathway exist in yeast such as Saccharomyces cerevisiae this single cell eukaryote provides an ideal model for studying the effects of test substances eg. dietary constituents on DNA repeat instability in humans.
- human cell lines can be used directly in the assays of the invention, the cell lines being derived from the cancer of interest eg. human colorectal cancer, especially hereditary non-polyposis cancer (HNPCC).
- the assay may use prokaryotic cells, conveniently bacterial cells such as Escherichia coli.
- the invention provides an assay comprising testing the carcinogenic properties of a test substance using yeast cells according to the first aspect of the invention; and further testing the test substance using human cells according to the first aspect of the invention.
- yeast cells are easier to work with than human cells
- the first step of the assay according to the second aspect of the invention provides a primary screening step which can be used to screen out test substances exhibiting undesirable carcinogenic properties before the second step whose results have greater significance in humans.
- the invention provides an assay for testing the carcinogenic properties of a test substance comprising the steps of: (i) screening a test substance using a reporter gene expression vector according to the first aspect of the invention; and (ii) repeating the assay using cells containing a high, medium, low or single copy number vector, the high, medium, low or single copy number vector being selected depending on the frequency of repetitive DNA instability measured in step (i).
- the reporter gene expression vector in step (i) is contained in d e cells at a high copy number.
- the assay according to the third aspect of the invention is particularly useful when the frequency of instability in step (i) is very high in cells which have not been exposed to the test substance. By selecting medium, low or single copy number vectors the background instability can be reduced as desired to make the assay more sensitive.
- Figure 1 shows the steps of a preferred assay according to the first aspect of the invention.
- the assay utilises a preferred assay plasmid of the invention
- Figure 1A shows the high copy assay plasmid pKa3-9(n) as previously described.
- the unique EcoRI site into which the respective tracts were cloned is underlined. Also underlined is the unique Stul site situated within the URA3 gene, used for the insertion of the KanMX4 cassette (cf. text for further details).
- Figure IB shows the high copy assay plasmid pKa3-9(n)KanMX4 utilising the dominant selectable marker KanMX4. Both the EcoRI site into which the respective tracts were cloned and the additional EcoRI site derived from the KanMX4 cloning step are underlined (cf. text for further details).
- Figure 2 shows a yeast/Zs. coli shuttle vector suitable for fusing yeast promoter and coding sequences to the lacZ gene of E. coli;
- Figure 2A shows the centromere-based assay plasmid pKaCEN(n) as previously described.
- the unique EcoRI site into which the repetitive tracts were cloned is underlined. Also underlined is the unique St ⁇ l site situated within the URA3 gene, used for the insertion of the KanMX4 cassette (cf. text for further details).
- Figure 2B shows the centromere-based assay plasmid pKaCEN(n)KanMX4 utilising the dominant selectable marker KanMX4. Both the EcoRI site into which the repetitive tracts were cloned and the additional EcoRI site derived from the KanMX4 cloning step are underlined (cf. text for further details).
- Figure 3 shows a low copy number vector containing sequences from yeast centromere VI
- Figure 4 shows a vector which lacks a yeast origin of replication, so that it must be integrated into the yeast genome for stable maintenance;
- Figure 5 shows a preferred high copy number reporter gene expression vector according to the invention;
- Figure 6 shows a preferred low copy number reporter gene expression vector according to the invention
- Figure 7 shows a preferred single copy integrative reporter gene expression vector according to the invention
- Figure 8 is a schematic representation which shows integration of the vector of Figure 7 at the URA3 locus of S. cerevisiae strain YN94-1;
- Figures 9 and 10 show the results of experiments to confirm insertion of the integrative vector of Figure 7 into the S. cerevisiae strain as illustrated in Figure 8;
- Figure 11 shows the synthetic pathway for the polyamines putrescine, spermidine and spermine in eukaryotes
- Figure 12 is a schematic representation of frame-slippage in the preferred vectors leading to ⁇ -galactosidase reporter gene expression
- Figures 13a and 13b shows a Southern blot analysis of MSH2 genomic DNA (Figure 13a) and the disruption scheme (Figure 13b);
- Figure 14 shows a Southern blot analysis of wild type and disrupted MLH1 gene
- Figure 15 shows a vector incorporating the SV40 promoter upstream of the luciferase gene
- Figures 15a and 15b show Southern blot analysis of YN97-150 (msh :: KanMX4);
- Figure 16 shows an EBV-based vector for stable expression of DNA in human host cells;
- Figures 16a and 16b show Southern blot analysis of YN97-167
- Figure 17 shows the effect of a known carcinogen on the instability of the high copy number expression vector of Example 1(1).
- Figures 17a and 17b show Southern blot analysis of YN98-3 (pol 130-104 : : LEU2);
- Figure 18 is a schematic outlining biosynthesis of purine nucleotides, from Jones and Fink, 1982.
- YN94-1 MATa, ade2-l, his3-ll, leu2-3, 112, trpl-1, ura3-l, canl-100.
- DH5 F,_80/ ⁇ cZ ⁇ M15 ⁇ (/ ⁇ cZYA-argF)U169 deoR recAl endAl yR17(r ⁇ -, m ⁇ +) phoA sup ⁇ AA ⁇ - thi-l gyrA96 relAl .
- JM109 el4-(McrA-) rec Al endAl gyr A96 thi-l hdsRll (r ⁇ -m ⁇ + ) sup ⁇ A ⁇ rel Al A(lac-proAB) [F' tr ⁇ D36 pro AB
- RR1 F-, hsdS20 (r B -, m B -), supE44, araU, proAl, rpsL20 (str), syl-5, mlt-5, supE44, ⁇ -.
- yeast nitrogen based - without amino acids and ammonium sulphate (Difco, Detroit, USA)
- ampicillin is added to a final cone, of lOO ⁇ g/ml when the media has cooled to approximately 55 °C.
- LacZ Reverse 529 5'-AAGGGGGATGTGCTGCAAGG-3' 509
- YEp Forward 8271 5'-GCAGCGAGTCAGTGAGCGAGG-3 8291
- PRS3 Forward - 50 5 '-GATTCATACTCTTTTTTCTACG -3 ' _ 81
- the numbers in subscript indicate the positions of annealing relative to the ATG start codon of PRS3.
- Oligonucleotide 2 (poly d(TG) 15 T, with an EcoRI restiction site overhang at its 5 '-end and a Smal site at its 3 '-end botibi indicated by underlining, giving a total length of 46 nts).
- Telomeric oligonucleotide 2 (80 nt, poly d(Gj- 3 T), with an EcoRI restriction site overhang at its its 5'- end and a Smal site at its 3 '-end both indicated by underlining, giving a total length of 80 nts).
- poly d(A) 20 with an EcoRI restriction site overhang at its 5 '-end and a Smal site at its 3 '-end both indicated by underlining, giving a total length of 35 nts).
- Loss of growth selection may be encountered when yeast strains containing the plasmid-borne URA3 marker are grown on a non-selective medium. This can occur when whole food extract containing growth- sustainable amounts of uracil are added to the medium.
- This problem can be overcome using a plasmid-borne KanMX4 dominant selectable marker consisting of the E. coli transposon Tn903 fused to the transcriptional control sequences of the TEF gene of the filamentous fungus Ashbya gossypii.
- This hybrid molecule permits the efficient selection of yeast transformants resistant to geneticin (G418) (Wach et al. 1994).
- Assay plasmids as described above containing the URA3 gene were linearised by digestion at die unique Stul restriction enzyme site (Promega), (+436 relative to the URA3 start codon). 40 ng of this linearised vector was ligated to 200 ng of a gel-purified 1481 bp EcoRV/Smal fragment from pFA6-KanMX4 (Wach et al. 1994) containing the KanMX4 cassette. An aliquot of this ligation mixture was then transformed into the E. coli strain RRl and colonies growing on kanamycin were selected. Plasmid DNA was isolated from several kan- resistant colonies and subjected to restriction analysis. (The insertion of the KanMX4 cassette introduces a second EcoRI site into the assay plasmids as illustrated by comparing Figure 1A with IB and 2A widi 2B.)
- the MSH2 gene of Saccharomyces cerevisiae (cf. Fig. 1) is one of several genes that share extensive homology with the bacterial MutS gene. Located on chromosome XV it encodes a protein of 109kda. Like the MutS protein, the MSH2p binds selectively to DNA containing mispairs and substrates containing up to 14 extra bases. Strains that contain mutated MSH2 genes have strongly elevated rates of spontaneous mutations and exhibit microsatellite instability (cf. Table 1).
- MSH2 gene of Saccharomyces cerevisiae TN94-1 was disrupted with LEU2 (Fig. 13).
- Plasmid pRhB113 (Rhona Borts, Yeast Genetics, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford 0X3 9DU) containing die MSH2 gene disrupted with LEU2 at the SnaBI site was digested to completion with restriction enzyme Spel in buffer REactl (cf. Materials and Methods). The digestion mixture was transformed directly into S. cerevisiae YN904-1 (cf. Materials and Methods). Resulting transformants were then screened by Southern hybridization for die presence of the disrupted MSH2 gene ( Figures 13a and b).
- FIG. 13a Southern blot analysis of YN97-10 (msh2::LEU2)
- the MLHl gene of Saccharomyces cerevisiae is one of several genes that shares extensive homology with the bacterial MutL gene. It is believed d at MLHlp forms an interaction with MSH2p during die initiation of DNA mismatch repair in yeast. Yeast strains that contain mutated MLHl genes have strongly elevated rates of spontaneous mutations and also exhibit microsatellite instability (cf. Table 1). The MLHl gene of Saccharomyces cerevisiae YN94-1 was disrupted with LEU2.
- Plasmid pREdl82 (Rhona Borts, Yeast Genetics, Institute of Molecular Medine, John Radcliffe Hospital, Oxford OX3 9DU) containing the MLHl gene disrupted with LEU2 was digested to completion with the restriction enzymes SacllBam l in buffer REact 3 (cf. Materials and Methods). This digestion mixture was transformed directly into S. cerevisiae YN94-1 (cf. Materials and Methods). Resulting transformants were then screened by Southern hybridization for the presence of the disrupted MLHl gene on chromosome XIII (Fig. 14).
- the MSH3 gene of Saccharomyces cerevisiae is another gene that shares extensive homolgy with the bacterial MutL gene.
- MSH3p forms a heterodimer with MSH2p during the initiation of insertion/deletion mismatch repair.
- Yeast strains mutant for MSH3 exhibit a less profound increase in microsatellite instability as compared to MSH2 and MLHl mutant strains and have slightly elevated levels of spontaneous mutations (Strand et al. 1995).
- MSH3 The MSH3 gene of Saccharomyces cerevisiae YN94-1 was disrupted widi LEU2.
- pREd62 Rhona Borts, Yeast genetics, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU
- Aatll the restriction enzyme
- the MSH6 gene of Saccharomyces cerevisiae is a further gene that shares extensive homolgy with the bacterial MutL gene.
- MSH6p forms a heterodimer with MSH2p during the initiation of spontaneous base-base mismatch repair (Alani et al. 1996).
- Yeast strains mutant for MSH6 exhibit a less profound increase in microsatellite instability as compared to MSH3 mutant strains but have elevated levels of spontaneous mutations in comparison to MSH3 mutant strains.
- the MSH6 gene of Saccharomyces cerevisiae YN94-1 was disrupted with KanMX4.
- This MSH6 disruption plasmid (Rhona Borts, Yeast genetics, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU) was created by cloning a 4 kb PCR fragment containing the MSH6 gene into the Sr ⁇ site of pPCR script (Sratagene).
- a Pvull to EcoRV fragment containing the KanMX4 module (Wach et al. 1994) was men used to replace a SnaBl to Spel fragment of the MSH6 open reading frame to create plasmid pSRC9.
- the msh6::KanMX4 disruption cassette was released by digestion with restriction enzymes Sphl and - ⁇ -ypEI and transformed into YN94-1 (cf. Materials and Methods). Resulting yeast transformants were then screened by Southern hybridization for the presence of the disrupted MSH6 gene on chromosome IV.
- the RTH1 (RAD27) gene of Saccharomyces cerevisiae is one of several genes encoding a 5' ⁇ 3' DNA exonuclease. Subsequent mutations arising in rthl strains are duplications resulting from a novel mutagenic process, and are not due to a defect in mismatch repair (Tishkoff et al. 1997). During replication of the lagging strand, DNA polymerase extends into the downstream "Okazaki" fragment and displaces it, resulting in a 5' "flap" structure that is normally removed by RTHlp. In the absence of this exonuclease, extensive strand displacement synthesis occurs resulting in the duplication of DNA sequences.
- the rthl::KanMX4 disruption strain was constructed using standard techniques.
- RTHl was amplified by PCR using primers .
- These primers were made in-house at the 40 nmole scale.
- Conditions for amplification were as follows: 50 ng YN94-1 genomic DNA template, 0.8 ⁇ l 25mM dNTPs (dATP, dCTP, dGTP, dTTP, Pharmacia) mix, l ⁇ l each primer (200 pmole), 10 ⁇ l lOx Amplitaq ® (Applied Biosystems) buffer, 2 units Amplitaq ® enzyme made up to 100 ⁇ l with dist. H 2 0 and overlaid with paraffin oil. A Hybaid thermocycler was used. Programme: 92°C for 2 min for 1 cycle; then 92°C for 2 min, 50°C for 3 min, 72°C for 3 min. for 30 cycles.
- the reaction was then precipitated using 10 ⁇ l sodium acetate pH5.2 and 200 ⁇ l ethanol for 30 min on ice.
- the DNA was men centrifuged at 15000g for 20 min. The pellet was then washed in 75 % e ⁇ anol and dried in vacuo before being resuspended in 30 ⁇ l H 2 O.
- the resulting PCR product was cloned into S/w ⁇ l-digested pUC19 (Yannisch-Perron et al. 1985) creating plasmid pKLRTHl .
- a 1481 bp Sm ⁇ l/EcoRV-derived fragment containing the KanMX4 cassette was removed from pFA6-KanMX4 (Wach et al. 1994) and cloned into the ⁇ coRV site of pKLRTHl (+66 relative to the RTHl start codon) creating disruption plasmid pKLrthl: :KanMX4.
- the rthl disruption cassette was released by Hpal digestion and men transformed into YN94-1.
- G418, Life Technologies For selection of transformants geneticin (G418, Life Technologies) was added to the media at a final concentration of 200 ⁇ g/ml. Putative yeast disruptions were checked by Southern hybridization for the disrupted gene on chromosome XI and for the rthl temperature sensitive phenotype (Sommers et al. 1995).
- PCNA proliferating cell nuclear antigen
- Plasmid pCH1577 (Amin & Holm, 1996) containing the pol30-104 allele marked with the LEU2 gene was digested to completion with Sacl. The reaction products were transformed directly into S. cerevisiae YN94-1. Putative disruptions were patched and first checked for the cold sensitive phenotype (inability to grow at 15 C) then by Soudiern hybridization analysis and finally by sequencing which revealed the expected nucleotide exchange of a C to a T at position 752 which results in the replacement of alanine by valine in the translated product.
- the SFH disruption cassette (Wach et al. 1994) was amplified from pFA6- KanMX4 by PCR using Amplitaq ® (Applied Biosy stems). Two primers were designed consisting of 40 bases of flanking sequence of MSH2 and 20 bases complementary to the KanMX4 cassette.
- the primers SFH1 are identical to the primers SFH1 :
- the PCR product was then precipitated using 10 ⁇ l 3 M sodium acetate pH 5.2 and 200 ⁇ l edianol for 30 min on ice.
- the DNA was the centrifuged at 15,000 g for 20 min.
- the pellet was then washed in 75% edianol and vacuum dried before being resuspended in 50 ⁇ l of dist. H 2 O. Transformation of yeast was carried out according to the method of Gietz and Woods (1994). For selection, geneticin (G418)-supplemented medium was used. Putative yeast disruptions were checked by Direct Colony PCR (Pearson and McKee, 1991) using the following primers.
- Cells were then frozen at -70 °C or used directly for transformation.
- lOO ⁇ l of cell suspension was added to a pre-cooled reaction tube together with 4 ⁇ l (1-lOng) of transforming DNA. This was then left on ice for 30 minutes. Cells were then heat-shocked for 45 seconds at 42 °C and dien incubated on ice for 4 minutes. 1ml of LB medium was then added and the cells were incubated at 37 °C for 1 hour. This was then plated directly onto selective media LB plates and incubated overnight at 37 °C.
- PLATE 90ml 45 % PEG 4000 10ml 1M Li-acetate lml 1 M Tris-HCI, pH 7.5 0.2ml 0.5 M EDTA
- the yeast strain was streaked out for single colonies onto YEPD agar and incubated overnight at 30°C. A single colony was picked and grown overnight in 10ml YEPD at 30°C with shaking.
- 0.5ml of ie culmre was spun down in a microcentrifuge (Sigma 112) and me supernatant was decanted by inversion.
- lO ⁇ l of carrier DNA (lOO ⁇ g) and l ⁇ g transforming DNA was men added (no transforming DNA was added for control) and vortexed.
- 0.5ml PLATE was then added, vortexed and incubated overnight at room temperature. Cells were then pelleted, washed and resuspended in 125 ⁇ l glass dist. H 2 O. This was then plated directly onto selective media and incubated at 30 °C for 3 days.
- Resuspension buffer 50 mM Tris-HCI
- Sorbitol/Tris/EDTA 1.2 M sorbitol 10 mM EDTA
- RNase A RNase A, lOmg/ml (Sigma, Dorset, UK) - boiled for 10 minutes, then snap cooled.
- restriction digests were performed in a total volume of 30 ⁇ l. 20 ⁇ l of DNA (0.2-l ⁇ g) was digested with 2 ⁇ l of enzyme, 3 ⁇ l of lOx restriction buffer and 5 ⁇ l glass dist. H 2 O. The reaction was incubated according to the manufacturer's instructions for a minimum of 3 hours. For restriction analysis, digests were performed in a total volume of lO ⁇ l. l ⁇ l of DNA was digested with l ⁇ l of enzyme, l ⁇ l of the appropriate buffer and 7 ⁇ l glass dist. H 2 0. This was then incubated according to the manufacturer's instructions for 1 hour. Enzymes were then inactivated by heating at 60 °C for 10 minutes.
- Tris-borate (lxTBE) buffer 0.089 M Tris-base
- Efhidium bormide (working cone. 0.5 mg/ml) Tris-HCI 20 mM pH 8 EDTA 1 mM pH 8
- T4 DNA ligase (Promega-Biotec, Madison, USA) lx ligase buffer (Promega-Biotec, USA): 50 mM Tris-HCI, pH 7.8
- Ligations were carried out in a total volume of lO ⁇ l. Approximately 0.1 ⁇ g of vector DNA and the appropriate amount of insert DNA was added to a sterde microfuge mbe. Reaction was made up to 7.5 ⁇ l with glass dist. H 2 0. For cohesive end ligation, the reaction was warmed to 65 °C for 5 minutes, 37 °C for five minutes, room temperamre for five minutes, then 4°C for five minutes. l ⁇ l ligase buffer and l ⁇ l T4 ligase was added and the reaction was men incubated overnight at 20 °C for cohesive ends, or at 10 °C for the ligation of blunt-ended DNA. l-4 ⁇ l of the ligation mixture could men be used for transformation of E. coli.
- Tris-borate TBE buffer (cf. earlier) Agarose (Life technologies Inc. , Paisley, UK) 0.25 M HCl Denaturation solution: 1.5 M NaCL
- Hybridization buffer 0.2 M (Amersham Life Sciences, ECL Gold hybridization buffer, with 5 % (w/v) blocking agent and 2.2 M NaCl) SDS 1 %
- Pre-digested genomic DNA was run on a 1 % agarose gel in lxTBE. The gel was then immersed in 0.25 M HCl and agitated for 7 minutes. This was then rinsed twice with dist. H 2 O and immersed in denaturation solution for 30 minutes. After rinsing with deionised H 2 O die gel was immersed in neutralization solution for 30 minutes. The DNA was then transferred to Hybond-N with 20xSSC using a vacuum blotter (Appligen, Durham, UK) at 60 mbar for 1 hour. DNA was cross-linked onto the membrane in a Stratalinker 2400 (Stratagene, Cambridge, UK), using the autocrosslink mode (120,000 ⁇ joules/30 sec). The blot was then placed in a glass hybridization mbe (80 x 200 mm, Techne, Cambridge, UK), and 25ml hybridization buffer was added. The blot was then pre-hybridized for 15 minutes at 42°C.
- the DNA fragment to be labelled was diluted to a concentration of lOng/ ⁇ l in glass dist. H 2 0. lOOng (lO ⁇ l) was then denatured by boiling for 5 minutes. The DNA was immediately cooled on ice for 5 minutes and briefly spun in a microcentrifuge. lO ⁇ l of ECL DNA labelling reagent was added to the cooled DNA and mixed. lO ⁇ l of ECL glutaraldehyde was added and mixed. This was dien incubated at 37 °C for 10 minutes. The probe was then added to me hybridization solution at a final concentration of lOng/ml.
- the blot was hybridized overnight in a Techne-oven (Hybridizer HB-1D, Techne, Cambridge, UK) at 42°C and then washed at 65 °C with 2x SSC and 1 % SDS. A second wash was carried out widi 0.5x SSC and 0.1 % SDS. The blot was men exposed to luminescence detection film (Hyperfilm-ECL, Amersham, UK) for various lengths of time.
- Taq polymerase buffer lOx (Perkin Elmer, Cheshire, UK) 500 mM KCI
- Single yeast colonies were picked widi a sterile tip and mixed widi lO ⁇ l glass dist. H 2 0 in a 0.5ml reaction tube and placed on ice.
- a mix containing lOO ⁇ l polymerase buffer, 780 ⁇ l H 2 O, 8 ⁇ l dNPTs, 4 ⁇ l of each primer and 5 ⁇ l Taq polymerase was then made up and vortexed briefly. 90 ⁇ l of this mix was added to each reaction mbe and sterile oil was added to prevent evaporation.
- PCR product was purified using PCR purification resin according to the manufacturer's instructions and redissolved in lOO ⁇ l glass dist. H 2 0.
- reaction products were identified by running 15 ⁇ l of the assay on a 2% agarose gel in lxTBE.
- KPP Phosphate buffer
- volume activity was then calculated for each sample using die following equation:
- VOLUME ACTIVITY 1000 x V ⁇ x OD 420
- V E extract volume (25 ⁇ l)
- Unit Definition (U) one unit (U) of ⁇ -galactosidase hydrolyses 1 nMol ONPG per minute under me above conditions.
- total cell extract protein To determine specific ⁇ -glactosidase activity, total cell extract protein must be quantified.
- 25 ⁇ l cell extract was made up to 800 ⁇ l widi glass dist. H 2 0. 200 ⁇ l of Bradford solution was then added, vortexed and incubated at room temperamre for 10 minutes. OD 595 was then measured (Ultraspec 2000, Pharmacia Biotech, St. Albans, UK) and protein concentration (mg/ml) was determined using a bovine serum albumin calibration curve.
- V E extract volume (25 ⁇ l)
- V ⁇ total Reaction volume (1725 ⁇ l)
- Cp protein Concentration (mg/ml)
- dt time (min)
- Unit Definition (U) one unit (U) of ⁇ -galactosidase hydrolyses 1 nMol of ONPG per minute under the above conditions.
- each oligo was run on a 4% acrylamide gel in lxTBE at 100 volts. Single stranded DNA bands were shadowed by UV using a fluorescent TLC plate and cut out. DNA was eluted from gel fragments into 200 ⁇ l glass dist. H 2 0 by shaking overnight and precipitated using standard procedures.
- Nucleotide sequences were determined by automated DNA sequencing based on me chain-termination method using die ABI 373A sequencer (Applied Biosy stems, Foster City, California, USA). Double stranded DNA was sequenced using the 'Taq DNA polymerase dideoxy terminator cycle sequencing kit' (Applied Biosystems), with primers; lacZ Reverse and YEp Forward (cf. Materials and Methods).
- the preferred system utilises a unique group of yeast vectors containing die bacterial lacZ gene (minus die promoter and first 7 codons) fused to die first 29 codons and promoter region of the yeast gene PRS3 (5- phospho-ribosyl-l( ⁇ )-pyrophosphate syndietase) (Carter et al. 1994).
- This functional gene fusion was preferably knocked out-of-frame (-1 reading- frame) by the insertion of a poly d(AC) ⁇ 6 tract at die EcoRI site downstream of the PRS3 promoter and within the coding region initiated from the ATG of PRS3.
- the resulting PRS3'/lacZ gene fusion containing this out-of-frame insertion was inserted into each of three yeast vectors: a high copy vector, a low copy vector and a single copy integrated into the yeast genome.
- the initial PRS3'/lacZ fusion was constructed by die insertion into the multiple cloning region of Y ⁇ p356R (Fig. 2, Materials and Methods) (Myers, A.M. , et al. 1986) of a 371 bp DNA fragment comprising the promoter region and regulatory elements of the yeast gene PRS3.
- This 371 bp HpallClal fragment (-284 - +85 relative to the PRS3 start codon) was rendered blunt and die resulting fragment ligated into the unique Smal site of YEp356R, creating plasmid pSS3-9.
- Oligonucleotides 1 and 2 (cf.
- the resulting 3680 bp fragment containing the -PRS5- 'lacZ fusion was gel purified (cf. Materials and Mediods).
- pRS416 was also digested to completion wi i NsiL and BamHl in buffer REactTM3 with the aim of removing the existing lacZ region on a 923 bp fragment.
- the resulting 3975 bp vector band containing die ARS and centromere sequences was gel purified and ligated to die 3680 bp fragment of pKa3-9(32-l) containing the PRS31LacZ fusion. In this way the 7655 bp plasmid - pKaCEN(32-l) (Fig. 6) was generated.
- the ligation mixture was then transformed into E. coli DH5 ⁇ (cf. Materials and Mediods) and placed onto LB + ampicillin plates. DNA from resulting colonies was purified using the rapid alkaline extraction procedure (cf. Materials and Mediods) and screened by restriction analysis. The low copy centromere-based plasmid exists episomally at levels of 1-5 copies per cell (see Fig. 6).
- pKaINT(32-l) involved removal of the PRS3 'llacZ fusion containing the poly d(AC) 16 tract from pKa3-9(32-l) on a BamHl/ Nsil fragment. This fragment was subsequently cloned into BamHl/Nsil digested integrative plasmid YIp352 (cf. Fig. 4, Materials and Methods (Myers et al. 1986)). Before pKaINT(32-l) could be integrated into the yeast genome it was linearised by restriction at its unique Ncol site located witiiin the URA3 gene.
- lane 6 gives the same banding pattern as the control YN94-1 in lane 1. This pattern may be due to recombination between the repeated URA3 genes on chromosome V. In this way me integrated vector is lost and the URA3 mutation reverts to wild type, hence growth on selective media and loss of the 3680 bp band on the blot.
- EXAMPLE 2 Sensitive screening system in S. cerevisiae utilising the luciferase reporter gene
- URA3 orotidine-5 ' -phosphate decarboxylase
- Cells in which the URA3 gene is expressed can be selected against by growth on plates containing 5-fluoro-orotate (5-F0A).
- This screening system involves the construction of a similar plasmid to that used in die yeast system.
- a fragment containing the luciferase gene is removed from pGL3-Promter vector (Fig. 15) and replaced with a fragment derived from one of the three assay plasmids described in Example 1.
- This fragment derived from the assay plasmid contains me poly(AC) 16 tract fused to die ⁇ -galactosidase reporter gene minus the yeast promoter and start codon. Cloning of mis fragment into pGL3-Promter vector results in an SV40/lacZ fusion containing a poly(AC) 16 tract in the open reading frame.
- EBV Epstein-Barr virus
- Selection in human cultured cells is by incorporation of a fragment containing the hygromycin resistance gene also derived from plasmid pDR2 (cf. Fig. 16).
- the cells are derived from mmours of colorectal cancer patients or other mmours which exhibit instability in repetitive (microsatellite) DNA sequences.
- human cell lines can be engineered to contain mutations in genes implicated in mismatch repair pathways, such as hMSH2 and/or hMLHl, using standard mutagenesis techniques wimin the knowledge of a skilled person.
- the following vectors are used to transform human cell lines in me same way mat me vectors of Examples 1 and 2 are used to transform yeast cells according to preferred embodiments of the assay according to the first aspect of the invention.
- EXAMPLE 4 Assay for testing the carcinogenic properties of a test substance
- me test system of the invention me background frequency of microsatellite instability associated widi wdd type (mismatch repair- competent) and strains defective in DNA mismatch repair has been assayed. As shown in Table 1 die yeast strains defective in mismatch repair show extensive DNA instability. This situation can be compared to the DNA instability observed in cell lines derived from colorectal carcinomas.
- Table 1 Frequency of alternation in lengths of poly (AC) tracts in wild type yeast strains and DNA mismatch repair mutants.
- the wild-type yeast strain for mismatch repair - YN94-1 - shows a low background white to blue frame-shifting frequency when transformed with constructs described above in the context of high copy 2 micron-based yeast origin of replication.
- Frequency of instability increases relative to the lengdi of the repetitive tract (obviously a longer tract is more likely to undergo mutational change than a shorter one).
- Frequency of instabilities are approximately 10-fold lower in constructs in the context of the centromere-based vectors compared to the high copy constructs and approximately 100-fold lower in the single copy integrative assay constructs.
- telomeric tract For the high copy construct containing the (C ⁇ A)-, telomeric tract the frequency of alteration was approximately 3xl0 "5 suggesting mat telomeric repeats are much more stable than poly (AC) tracts. In this way, the overall sensitivity of the assay system can be altered dirough a choice of plasmid copy number and repetitive tract leng i. Little difference in slippage-frequency was seen between die constructs in the -1 reading-frame compared to those in the + 1 reading frame when measured in me wild type strain, indicating no bias towards insertions or deletions. The sequence of the d(AC) tract in plasmids rescued from blue colonies was determined as described.
- the pol30-104 mutation in PCNA causes an approximately 20- 100-fold increase in me frequency of tract alteration as compared to wild type.
- the effect of pol30-l 04 on tract alterations is not quite as severe as that of the null mutations in the mismatch repair genes (cf Table la).
- Epistatic analyses of pol30-104 with null mutations in mismatch repair genes MSH2, MLHl and PMS1 have shown that rates of tract instability were the same in double mutants of pol30-104 with null mutations in mismatch repair genes and in single mismatch repair mutants (Johnson et al. 1996). Therefore, it can be said that hypermutability in this mutant results from a defect in mismatch repair.
- the acmal slippage event was identified by DNA sequencing using primer "PRS3 Forward" (cf. Materials and Mediods). The procedure used was based on the chain-termination method (Sanger et al. 1977) using the ABI 373 A sequencer (Applied Biosy stems, Foster City, California, USA) (cf. Materials and Mediods).
- Sequencing of the repetitive region within the three assay plasmids revealed mat the blue yeast colony on a plate corresponded to a slippage event at the DNA level.
- the most frequent slippage event was the loss of one (AC) pair, the result of which shifted the coding region of the PRS3 'lacZ fusion back into the correct reading frame giving rise to a functional gene product (Fig. 12).
- AC loss of one
- resulting in-frame variants of the high copy, low copy integrative assay plasmids were measured for specific ⁇ -galactosidase activity in yeast (Fig. 12).
- the intercalating agent ethidium bromide and its effect on microsatellite instability causes frame-slippage through its action of intercalation.
- This and other intercalating agents preferentially target monotonic runs or alternating nucleotide sequences. As shown in Figure 17, at higher concentrations (6-7 ⁇ g/ml) this agent increases the frequency of frame-slippage 300 fold compared to an untreated strain (cf. Figure 1).
- Yeast strain YN94-1 was transformed with pKa3-9(32 1) and plated onto selective medium (cf. Materials and Methods). A single colony was inoculated into 100ml SCD-UracU (cf. Materials and Methods) and grown to mid-log phase. Culmre was divided into 10 x 10ml sterile bottles. Cells were harvested, washed in 0.1 M potassium phosphate (KPP) buffer (pH 6.5) then resuspended in KPP buffer at a concentration of approximately 10 6 cells/ml. Ethidium bromide was then added to concentrations between 0 and 9 ⁇ g/ml, and die cells were incubated at 30 °C with agitation for approximately 7 hours.
- KPP potassium phosphate
- Polyamines - a group of flexible polycations are normal constituents of the cell and are essential for many cellular processes. They are found in high concentrations in red meat, fish and vegetables. Under physiological conditions putrescine, spermidine and spermine are protonated and possess two, three and four positive charges respectively. Spermine, with its four positive charges binds two phosphate groups in each strand of the DNA helix. This spanning of the major and minor groove by spermine stabilises the DNA helix (Heby, O. & Persson, L. , 1990).
- Table 2 Frequency of alteration in lengths of poly(AC) tracts in wild type yeast strains and polyamine mutants.
- the mismatch repair pathway of eukaryotes repairs both insertion/deletion mismatches and spontaneous base-base mismatches. Therefore, using the above yeast strains we can use our assay to monitor the genetic and dietary influences on spontaneous base/base mismatches in yeast.
- yeast strains are derived from the wild type yeast YN94-1 available from Dr Michael Stark, Department of Biochemistry, University of Dundee, DD1 4HN, Dundee, Scotland, UK and Professor Michael Schweizer, Genetics & Microbiology Department, Institute of Food Research, Norwich Laboratory, Norwich Research Park, Norwich, NR4 7UA, England, UK and as such contain die ade2-l point mutation which affects the biosynmesis of purine nucleotides (Figure. 18).
- the red pigment that accumulates in adel and ade2 mutants derives from an intermediate formed in reaction 5.
- This step involves the closure of an imidazole ring by phosphoribosylaminoimidazole syndietase to yield phosphoribosylaminoimidazole (AIR).
- ADE2 cells do not accumulate this pigment and therefore remain white. Therefore, subsequent reversion of red ade - strains to wild type enables us to monitor the frequency of spontaneous mutations by a red to white colour transition.
- Table 3 Frequency of ADE + reversion in various yeast genetic backgrounds
- the identification of human dietary components mat protect against DNA instability and therefore some types of cancer by use of the present invention will contribute to the scientific basis for a healthy diet.
- the simple blue/white colour test according to a preferred embodiment can be provided in kit-form or scaled up for use in the food or pharmaceutical industries.
- test substance Once a test substance is identified as containing "protective" factors, programmes can be undertaken to characterize and elucidate the mode of actin of the protective factor within me foodstuff.
- the results from the assay of the invention should be of enormous value to plant and crop breeders who wish to produce foodstuffs of greater nutritional value. It has been observed diat drug resistant human ovarian carcinoma cell lines aquire a mutator phenotype and a deficiency in hMLHl repair activity, with loss of expression of the hMLHl subunit occurring in 9/10 independently derived cisplatin resistant sublines (Hirst et al. 1997).
- the assays of the invention include yeast strains carrying this mlhl mutation and so could be used in an in vivo s dy looking at the effects of cytotoxic agents and subsequent resistance.
- YN94-1 wild type (AC) 6 -1 1.40x10 " ' YN94-1 wild type (AC) 4 ,(A) 2 (C) 2 (AC) 4 A -1 1.72xl0 "4 YN94-1 wild type (AC) I2 A + 1 1.65x10 " ' YN94-1 wild type (AC) !5 A + 1 2.27x10 " ' YN94-1 wild type (AC) 24 A + 1 4.40x10 " '
- Phosphoribosylpyrophosphate synthetase PRS: a new gene family in Saccharomyces cerevisiae. Yeast, 10, 1031-1044. Elble, R. (1992). A simple and efficient procedure for transformation of yeast. Biotechniques, 13, 18-20. Eshelman, J.R. and Markowitz, S.D. (1995). Curr. Opin. Oncol. 7, 83-
- Saccharomyces - metabolism and gene expression p.271-278.
- RAD27 is distinct from DNA mismatch repair.
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9707141 | 1997-04-08 | ||
GBGB9707141.9A GB9707141D0 (en) | 1997-04-08 | 1997-04-08 | Biological assay |
PCT/GB1998/000869 WO1998045476A1 (en) | 1997-04-08 | 1998-04-08 | Biological assay for testing the carcinogenic properties of a substance |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0973946A1 true EP0973946A1 (en) | 2000-01-26 |
Family
ID=10810487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98917309A Withdrawn EP0973946A1 (en) | 1997-04-08 | 1998-04-08 | Biological assay for testing the carcinogenic properties of a substance |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0973946A1 (en) |
AU (1) | AU7055698A (en) |
GB (1) | GB9707141D0 (en) |
WO (1) | WO1998045476A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002095071A2 (en) * | 2001-05-22 | 2002-11-28 | Koninklijke Nederlandse Akademie Van Wetenschappen | Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7793587A (en) * | 1986-09-05 | 1988-03-10 | Medical Research Council | Mammalian cell mutagenicity screening test |
JPH03502882A (en) * | 1987-12-15 | 1991-07-04 | ザ トラスティーズ オブ プリンストン ユニヴァーシティ | Transgenic testing system for mutagens and carcinogens |
-
1997
- 1997-04-08 GB GBGB9707141.9A patent/GB9707141D0/en active Pending
-
1998
- 1998-04-08 AU AU70556/98A patent/AU7055698A/en not_active Abandoned
- 1998-04-08 EP EP98917309A patent/EP0973946A1/en not_active Withdrawn
- 1998-04-08 WO PCT/GB1998/000869 patent/WO1998045476A1/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO9845476A1 * |
Also Published As
Publication number | Publication date |
---|---|
GB9707141D0 (en) | 1997-05-28 |
AU7055698A (en) | 1998-10-30 |
WO1998045476A1 (en) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gulyas et al. | SSL2, a suppressor of a stem-loop mutation in the HIS4 leader encodes the yeast homolog of human ERCC-3 | |
Zou et al. | Holliday junctions accumulate in replication mutants via a RecA homolog-independent mechanism | |
Schär et al. | A newly identified DNA ligase of Saccharomyces cerevisiaeinvolved in RAD52-independent repair of DNA double-strand breaks | |
Ji et al. | Hotspots for unselected Ty1 transposition events on yeast chromosome III are near tRNA genes and LTR sequences | |
Veatch et al. | Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect | |
Burgess et al. | A mechanism to enhance mRNA splicing fidelity: the RNA-dependent ATPase Prp16 governs usage of a discard pathway for aberrant lariat intermediates | |
Schiestl et al. | Integration of DNA fragments by illegitimate recombination in Saccharomyces cerevisiae. | |
Eissenberg et al. | Mutations in yeast proliferating cell nuclear antigen define distinct sites for interaction with DNA polymerase δ and DNA polymerase ε | |
Kokoska et al. | Increased rates of genomic deletions generated by mutations in the yeast gene encoding DNA polymerase δ or by decreases in the cellular levels of DNA polymerase δ | |
Wang et al. | The yeast TFB1 and SSL1 genes, which encode subunits of transcription factor IIH, are required for nucleotide excision repair and RNA polymerase II transcription | |
Lee et al. | Posttranslational inhibition of Ty1 retrotransposition by nucleotide excision repair/transcription factor TFIIH subunits Ssl2p and Rad3p | |
Kohalmi et al. | Mutational specificity of DNA precursor pool imbalances in yeast arising from deoxycytidylate deaminase deficiency or treatment with thymidylate | |
Suto et al. | A double-strand break repair component is essential for S phase completion in fission yeast cell cycling | |
Sloan et al. | Effects of camptothecin or TOP1 overexpression on genetic stability in Saccharomyces cerevisiae | |
Last et al. | Isolation and characterization of the RNA2, RNA3, and RNA11 genes of Saccharomyces cerevisiae | |
Ciudad et al. | Homologous recombination in Candida albicans: role of CaRad52p in DNA repair, integration of linear DNA fragments and telomere length | |
Hryciw et al. | MMS1 protects against replication-dependent DNA damage in Saccharomyces cerevisiae | |
He et al. | A mutant of 7SL RNA in Yarrowia lipolytica affecting the synthesis of a secreted protein. | |
Bailis et al. | The essential helicase gene RAD3 suppresses short-sequence recombination in Saccharomyces cerevisiae | |
Muldoon-Jacobs et al. | Specific effects of ribosome-tethered molecular chaperones on programmed− 1 ribosomal frameshifting | |
Rosenfeld et al. | Hepatitis C virus internal ribosome entry site-dependent translation in Saccharomyces cerevisiae is independent of polypyrimidine tract-binding protein, poly (rC)-binding protein 2, and La protein | |
Hanna et al. | Pol32 is required for Polζ-dependent translesion synthesis and prevents double-strand breaks at the replication fork | |
WO1998045476A1 (en) | Biological assay for testing the carcinogenic properties of a substance | |
Cone et al. | Lac repressor mRNA transcription terminates in vivo in the lac control region. | |
Marykwas et al. | Mapping by multifragment cloning in vivo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19991108 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: THE INSTITUTE OF FOOD RESEARCH |
|
17Q | First examination report despatched |
Effective date: 20011214 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: LARKIN,KENNETH, JOHN Inventor name: SCHWEIZER, MICHAEL |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030213 |